{"id":164314,"date":"2019-08-09T18:30:05","date_gmt":"2019-08-09T18:30:05","guid":{"rendered":"http:\/\/www.georgianewsdesk.com\/news\/story\/164314\/cancer-biomarkers-market-analysis-upcoming-revenue-with-the-142-cagr.html"},"modified":"2019-08-09T18:30:05","modified_gmt":"2019-08-09T18:30:05","slug":"cancer-biomarkers-market-analysis-upcoming-revenue-with-the-142-cagr","status":"publish","type":"post","link":"http:\/\/www.honolulunewsnow.com\/news\/story\/164314\/cancer-biomarkers-market-analysis-upcoming-revenue-with-the-142-cagr.html","title":{"rendered":"Cancer Biomarkers Market Analysis Upcoming Revenue with the 14.2% CAGR"},"content":{"rendered":"
\"Cancer<\/a><\/p>\n
\n
High Prevalence and Incidence of Cancer is expected to Drive Growth of the Cancer Biomarkers Market<\/div>\n<\/div>\n<\/div>\n
Growing Research and Development Funding from Various Government and Private Organizations is a Factor Driving Growth of the Cancer Biomarkers Market<\/p>\n<\/div>\n

Various government and private organizations are focusing on increasing investment in R&D for cancer biomarkers<\/a><\/strong>. This is owing to increasing incidence and prevalence of cancer, globally. For instance, in June 2018, Cancer Research UK, proposed funding of US$ 140,922 per year, through biomarker project for biomarker assay development, validation, and qualification for use in cancer clinical diagnosis.<\/p>\n

Furthermore, in March 2016, the National Cancer Institute (NCI) invested US$ 5.5 million in 2016, for setting up of laboratories to conduct research on biomarkers and biomarker assays for cancers of the breast, prostate, lung, and genitourinary organs, and also to those cancers, which have high incidence rate. In April 2016, University of Auckland received a US$ 10 million grant to conduct research in cancer biomarkers, from Auckland entrepreneur, Mr Liangren Li and his family. The grant was allocated for initiating the PROSPER (Profiling of Oncology Patients as part of Clinical care and Research) project. In 2016, National Cancer Institute (NCI) invested US$ 3.9 billion for cancer research activities, which accounts for 70.8% of overall NCI 2016 budget. It invested around US$ 533 million on cancer detection and diagnostic research activities.<\/p>\n

Request Sample Copy of This Report: https:\/\/www.coherentmarketinsights.com\/insight\/request-sample\/175<\/a><\/strong><\/p>\n

Moreover, in 2016, NCI allocated 40.4% of its funds for Research Project Grants (RPGs). Furthermore, in 2017, NCI budget increased by US$ 454 million (8.7%) from previous year (2016) for cancer research activities. These increasing research and development (R&D) activities in biomarkers is expected augment growth of global cancer biomarkers market.<\/p>\n

According to the World Cancer Research Fund (WCRF) International, 2015 data findings, 58% of the lung cancer cases were reported in emerging economies, in 2014. Hungary had the highest rate of lung cancer, followed by Serbia, and North Korea. Moreover, highest incidence of lung cancer was registered in North America and Europe, for the same year. According to the National Cancer Institute, in 2014, around 66,771 people were suffering from liver and intrahepatic bile duct cancer in the U.S. Liver and intrahepatic bile duct cancer represented 2.4% of all new cancer cases reported in the U.S. in 2014.<\/p>\n

Read Press Release on Cancer Biomarkers Market: https:\/\/www.coherentmarketinsights.com\/press-release\/cancer-biomarkers-market-to-surpass-us-337-billion-by-2025-847<\/a><\/strong><\/strong><\/p>\n

Detailed Segmentation:<\/strong><\/p>\n

By Biomarker Type:<\/strong><\/p>\n

Protein Biomarkers<\/p>\n

Genetic Biomarkers<\/p>\n

Other Cancer Biomarkers<\/p>\n

By Cancer Type:<\/strong><\/p>\n

Breast Cancer<\/p>\n

Lung Cancer<\/p>\n

Prostate Cancer<\/p>\n

Kidney Cancer<\/p>\n

Liver Cancer<\/p>\n

Other Cancers<\/p>\n

By End User:<\/strong><\/p>\n

Hospitals<\/p>\n

Academic and Cancer Research Institutes<\/p>\n

Ambulatory Surgical Centers<\/p>\n

Cancer Diagnostic Laboratories<\/p>\n

Moreover, obesity, diabetes, alcoholic liver disease (cirrhosis), chronic hepatitis B, hepatitis C infections, tobacco, and smoking are the most common risk factors for liver cancer. According to the Centers for Disease Control and Prevention (CDC), February 2018 data findings, each year in the U.S., around 22,000 men and 9,000 women suffer from liver cancer, and around 16,000 men and 8,000 women die from liver cancer. Thus, substantial increase in incidence and mortality rate of liver cancer in the country, is expected to boost growth of cancer biomarkers market, in the near future.<\/p>\n

Key players operating in the cancer biomarkers market include BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc.<\/p>\n

Purchase Copy of This Business Research Report: https:\/\/www.coherentmarketinsights.com\/insight\/buy-now\/175<\/a> <\/strong><\/strong><\/p>\n

About <\/strong>Us<\/strong>:<\/strong><\/strong><\/p>\n

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Coherent Market Insights<\/a>
Contact Person:<\/strong> Mr. Shah
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1-206-701-6702
Address:<\/strong>1001 4th Ave, #3200
City:<\/strong> Seattle
State:<\/strong> Washington
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.coherentmarketinsights.com\/insight\/buy-now\/175<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

High Prevalence and Incidence of Cancer is expected to Drive Growth of the Cancer Biomarkers Market Growing Research and Development Funding from Various Government and Private Organizations is a Factor<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts\/164314"}],"collection":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/comments?post=164314"}],"version-history":[{"count":0,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/posts\/164314\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/media?parent=164314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/categories?post=164314"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.honolulunewsnow.com\/news\/wp-json\/wp\/v2\/tags?post=164314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}